Showing 1 to 11 of 11 results


Eight Healthy Babies Born Using Three-Person IVF Technique
Eight healthy babies have been born in the UK using a new IVF technique involving DNA from three people to prevent mitochondrial diseases; the procedure, developed at Newcastle University, offers hope to families at risk of passing on life-threatening genetic disorders.
Eight Healthy Babies Born Using Three-Person IVF Technique
Eight healthy babies have been born in the UK using a new IVF technique involving DNA from three people to prevent mitochondrial diseases; the procedure, developed at Newcastle University, offers hope to families at risk of passing on life-threatening genetic disorders.
Progress
44% Bias Score


Successful Gene Editing Treats Rare Genetic Disease in Baby
A baby with severe CPS1 deficiency, a rare genetic disorder affecting approximately one in a million infants, received a custom gene-editing therapy using CRISPR base editing, resulting in significant health improvements within months, opening possibilities for treating other rare genetic diseases.
Successful Gene Editing Treats Rare Genetic Disease in Baby
A baby with severe CPS1 deficiency, a rare genetic disorder affecting approximately one in a million infants, received a custom gene-editing therapy using CRISPR base editing, resulting in significant health improvements within months, opening possibilities for treating other rare genetic diseases.
Progress
40% Bias Score


Successful Gene Editing Treatment for Rare Genetic Disease
A 9.5-month-old baby, KJ Muldoon, successfully received a custom CRISPR-based gene editing therapy for severe CPS1 deficiency, a rare genetic disease affecting approximately one in a million babies. The treatment significantly improved his health, demonstrating the potential of personalized gene the...
Successful Gene Editing Treatment for Rare Genetic Disease
A 9.5-month-old baby, KJ Muldoon, successfully received a custom CRISPR-based gene editing therapy for severe CPS1 deficiency, a rare genetic disease affecting approximately one in a million babies. The treatment significantly improved his health, demonstrating the potential of personalized gene the...
Progress
40% Bias Score


Gene Editing Therapy Shows Promise in Treating Rare Genetic Disorder
Nine-month-old KJ Muldoon, diagnosed with severe CPS1 deficiency, a rare genetic disorder affecting one in a million babies, is thriving after receiving a custom CRISPR-based gene editing therapy developed in six months by researchers at Children's Hospital of Philadelphia and Penn Medicine.
Gene Editing Therapy Shows Promise in Treating Rare Genetic Disorder
Nine-month-old KJ Muldoon, diagnosed with severe CPS1 deficiency, a rare genetic disorder affecting one in a million babies, is thriving after receiving a custom CRISPR-based gene editing therapy developed in six months by researchers at Children's Hospital of Philadelphia and Penn Medicine.
Progress
40% Bias Score


Bradford Study Reveals Increased Health Risks for Children of First-Cousin Marriages
A Bradford study tracking 13,000 children from 2007-2010 revealed that one in six were born to first cousins, mainly from the Pakistani community, leading to increased concerns about the health risks associated with consanguineous marriages and a debate about potential legal interventions.
Bradford Study Reveals Increased Health Risks for Children of First-Cousin Marriages
A Bradford study tracking 13,000 children from 2007-2010 revealed that one in six were born to first cousins, mainly from the Pakistani community, leading to increased concerns about the health risks associated with consanguineous marriages and a debate about potential legal interventions.
Progress
44% Bias Score


mvGPT: A Revolutionary Gene Editing Technology
Rice University researchers developed mvGPT, a compact gene editing technology enabling simultaneous gene editing, activation, and repression; successful in treating Wilson's disease, Type I diabetes, and Transthyretin amyloidosis.
mvGPT: A Revolutionary Gene Editing Technology
Rice University researchers developed mvGPT, a compact gene editing technology enabling simultaneous gene editing, activation, and repression; successful in treating Wilson's disease, Type I diabetes, and Transthyretin amyloidosis.
Progress
48% Bias Score

Three-Parent Baby Technique Shows Promise, Raising Ethical Concerns
British scientists successfully used a "three-parent" technique to help seven women have eight healthy babies free of inherited mitochondrial disorders; however, long-term risks and ethical concerns remain.

Three-Parent Baby Technique Shows Promise, Raising Ethical Concerns
British scientists successfully used a "three-parent" technique to help seven women have eight healthy babies free of inherited mitochondrial disorders; however, long-term risks and ethical concerns remain.
Progress
48% Bias Score

Personalized Gene Therapy Shows Promise in Treating Baby with Rare Metabolic Disorder
In February 2025, a baby born with a life-threatening metabolic disorder received a personalized gene therapy in the US, showing significant health improvements and enabling the baby to return home, representing a potential breakthrough for treating rare genetic diseases with personalized base editi...

Personalized Gene Therapy Shows Promise in Treating Baby with Rare Metabolic Disorder
In February 2025, a baby born with a life-threatening metabolic disorder received a personalized gene therapy in the US, showing significant health improvements and enabling the baby to return home, representing a potential breakthrough for treating rare genetic diseases with personalized base editi...
Progress
40% Bias Score

Gene Editing Therapy Shows Promise for Rare Genetic Disorder
A nine-and-a-half-month-old baby in Pennsylvania with severe CPS1 deficiency, a rare genetic disorder affecting roughly one in a million infants, is thriving after receiving a custom-designed gene editing therapy using CRISPR base editing, offering hope for millions with rare genetic diseases.

Gene Editing Therapy Shows Promise for Rare Genetic Disorder
A nine-and-a-half-month-old baby in Pennsylvania with severe CPS1 deficiency, a rare genetic disorder affecting roughly one in a million infants, is thriving after receiving a custom-designed gene editing therapy using CRISPR base editing, offering hope for millions with rare genetic diseases.
Progress
32% Bias Score

UK Parliament Debates Ban on First-Cousin Marriages Amid Health Concerns
Conservative MP Richard Holden's push for a UK law banning first-cousin marriage faces opposition from the Labour party, citing health risks and concerns about societal impact; studies show a concerning prevalence of first-cousin marriages within certain communities.

UK Parliament Debates Ban on First-Cousin Marriages Amid Health Concerns
Conservative MP Richard Holden's push for a UK law banning first-cousin marriage faces opposition from the Labour party, citing health risks and concerns about societal impact; studies show a concerning prevalence of first-cousin marriages within certain communities.
Progress
60% Bias Score

MSH3 Protein Identified as Driver of Huntington's Disease CAG Repeat Expansion
Research reveals that the DNA mismatch repair protein MSH3 drives CAG repeat expansion in Huntington's disease, offering hope for new treatments targeting the root cause of this devastating condition and potentially others with similar mechanisms.

MSH3 Protein Identified as Driver of Huntington's Disease CAG Repeat Expansion
Research reveals that the DNA mismatch repair protein MSH3 drives CAG repeat expansion in Huntington's disease, offering hope for new treatments targeting the root cause of this devastating condition and potentially others with similar mechanisms.
Progress
44% Bias Score
Showing 1 to 11 of 11 results